Intravitreal injection (IVI) of brolucizumab for the treatment of neovascular age-related macular degeneration results in variable occlusion of large or small retinal arteries, or both, and perivenular abnormalities, which characterize retinal vasculitis and intraocular inflammation (IOI), a study has found.
Treatment with antivascular endothelial growth factor (anti-VEGF), along with regular monitoring, minimizes the risk of long-term vision loss in patients with neovascular age-related macular degeneration (AMD), a recent study has shown.
Selective laser trabeculoplasty appears to be more favourable than medical therapy in the first-line treatment of patients with ocular hypertension and glaucoma, with the former associated with slower visual field (VF) progression, according to data from the Laser in Glaucoma and Ocular Hypertension Trial (LiGHT).
Increased dietary intake of multiple nutrients, such as minerals, vitamins, and carotenoids, protects against the risk of progression to late age-related macular degeneration, specifically geographic atrophy, according to a study.
Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.